Skip to content
Health Horizon

Health Horizon

Healthy Body Your Time in Health

Primary Menu Health Horizon

Health Horizon

  • Health Horizon
  • Health Technology Innovation
  • Global Health and the Health Crisis
  • Mental Health and Emotional Wellbeing
  • Genetics and Gene Therapy Research
  • Contact Us
    • Advertise Here
    • Privacy Policy
    • Sitemap
  • Home
  • receive

receive

A Pennsylvania baby is first to receive personalized gene therapy
  • Genetics and Gene Therapy Research

A Pennsylvania baby is first to receive personalized gene therapy

admin June 4, 2025 0

A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for...

Read MoreRead more about A Pennsylvania baby is first to receive personalized gene therapy
Infant with rare, incurable disease is first to successfully receive personalized gene therapy treatment
  • Genetics and Gene Therapy Research

Infant with rare, incurable disease is first to successfully receive personalized gene therapy treatment

admin May 25, 2025 0

News ReleaseThursday, May 15, 2025 NIH-supported gene-editing platform lays groundwork to rapidly develop treatments for other rare genetic diseases.A research...

Read MoreRead more about Infant with rare, incurable disease is first to successfully receive personalized gene therapy treatment
Kadakia to receive Yale’s Fall 2024 Global Health Spark Award
  • Global Health and the Health Crisis

Kadakia to receive Yale’s Fall 2024 Global Health Spark Award

admin December 13, 2024 0

The Yale Institute for Global Health has selected Indian American researcher Nidhi Kadakia and Aline Herlopian to receive the Fall...

Read MoreRead more about Kadakia to receive Yale’s Fall 2024 Global Health Spark Award

Recent Posts

  • CDC in Nigeria | Global Health
  • Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Global Health Updates: US & WHO News
  • Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Archives

  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023

Categories

  • Genetics and Gene Therapy Research
  • Global Health and the Health Crisis
  • Health Horizon
  • Health Technology Innovation
  • Mental Health and Emotional Wellbeing
  • News

Visit Us

showbox app

You may have missed

CDC in Nigeria | Global Health
  • Global Health and the Health Crisis

CDC in Nigeria | Global Health

admin February 23, 2026 0
Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Mental Health and Emotional Wellbeing

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News

admin February 23, 2026 0
Global Health Updates: US & WHO News
  • Global Health and the Health Crisis

Global Health Updates: US & WHO News

admin February 22, 2026 0
Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Genetics and Gene Therapy Research

Unlocking the Potential of Gene Therapy for Genetic Skin Disorders

admin February 21, 2026 0
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
  • Health Horizon

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

admin February 21, 2026 0
Copyright © All rights reserved. | CoverNews by AF themes.